Nuvation BioNUVB

紐約證券 · USD
4.58
-0.35
(-7.10%)
收盤 06/11 03:59 (UTC+8)
盤後 
4.58 
4.58 
(0.00%)
06/11 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • 0.01
  • 0.01
  • 0.06
  • 0.03
  • 0.05
  • 0.13
  • 0.42
  • 0.83
icon
  • -
  • -
  • -
  • -49.34
  • 685.56
  • -46.00
  • 56.71
  • 171.47
  • 219.09
  • 98.80
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
營業收入淨額
83,228
41,865
13,120
4,833
3,084
5,711
727
1,435
-
-
營業成本
5,9911,2793,3492,5762,0944,2161,5151,347--
營業毛利
77,237
40,586
9,771
2,257
990
1,495
-788
88
-
-
營業費用
73,35674,62366,20565,84659,99455,43747,313470,47320,19920,831
研發費用
35,04734,29728,84627,36224,60129,29927,73129,24712,84215,351
推銷及管理費用
38,30940,32637,35938,48435,39326,13819,58216,1567,3575,480
非經常性項目費用
-------425,070--
其他營業費用
----------
營業利益
3,881
-34,037
-56,434
-63,589
-59,004
-53,942
-48,101
-470,385
-20,199
-20,831
其他收入及費用
8,2244,1187,1765,0035,8224,5867,0118,0255,4077,044
利息費用
6,7086,6736,5344215489120132--
稅前純益
5,397
-36,592
-55,792
-59,007
-53,236
-49,445
-41,210
-462,492
-14,792
-13,787
所得稅
----------
稅後純益
5,397
-36,592
-55,792
-59,007
-53,236
-49,445
-41,210
-462,492
-14,792
-13,787
基本每股稅後盈餘(元)
0.02-0.11-0.16-0.17-0.16-0.15-0.15-1.89-0.07-
稀釋每股稅後盈餘(元)
0.01-0.11-0.16-0.17-0.16--0.05-1.99-0.07-0.07
基本平均股數(千股)
347332.00344339.00342393.00340746.00338612.00336934.00273565.00244738.00219048.00-
稀釋平均股數(千股)
377521.00344339.00342393.00340746.00338612.00336934.00273565.00244738.00219048.00-
還原基本每股稅後盈餘(元)
0.02-0.11-0.16-0.17-0.16-0.15-0.15-1.89-0.07-
還原稀釋每股稅後盈餘(元)
0.01-0.11-0.16-0.17-0.16--0.05-1.99-0.07-0.07
還原基本平均股數(千股)
347,332344,339342,393340,746338,612336,934273,565244,738219,048-
還原稀釋平均股數(千股)
377,521344,339342,393340,746338,612336,934273,565244,738219,048-
EBITDA(千元)
12,123-30,241-49,694-59,547-54,346-50,791-43,030-464,540-17,554-16,991

大家都在看

HOT